+67%

est. 2Y upside i

HealthcareSeries D+

Grow Therapy is an online platform that connects patients with therapists that are covered by insurance.

Rank

#976

Sector

Healthcare Technology

Est. Liquidity

~3Y

Data Quality

Data: High

Grow Therapy offers a strong equity opportunity given its 52% growth and $3B valuation ($3B/$1B revenue).

Last updated: July 3, 2026

Bull (20%)+100%

Bull case capped at +100% due to late-stage constraint. Requires IPO window opening and sustained growth to justify multiple expansion to ~3.2x forward revenue ($6B exit).

Base (40%)+90%

Base case assumes multiple maintains at ~3.0x forward revenue, yielding ~1.9x revenue growth translating to ~90% upside ($5.7B exit). Sustained execution and market expansion.

Bear (40%)+27%

Bear case sees multiple compression to ~2.0x due to increased competition or regulation, but revenue growth still yields ~27% upside ($3.8B exit). Common stock remains above preference stack.

Est. time to liquidity~3.0 years

Preference Stack Risk

moderate

Funding Intensity

11%

Total funding of $328M represents 10.9% of the $3B valuation, creating a moderate preference overhang.

Dilution Risk

low

No additional funding required within 2 years given recent Series D and revenue scale; dilution risk is low.

Secondary Liquidity

none

No secondary market activity detected; no liquidity options for employees.

Other — 37 roles

View all 37 open roles at Grow Therapy →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Grow Therapy's data — designed to show you've done your homework.

  • 1

    “How does Grow Therapy's platform differentiate from Alma and Headway in terms of therapist economics?”

  • 2

    “What is the company's path to profitability given the 1099 contractor scrutiny?”

  • 3

    “How do you evaluate the trade-off between potential upside and liquidity risk in a private company equity package?”

Community

Valuation Sentiment

Our model estimates +67% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.